Evaluate the Safety and Efficacy of ON101 Cream for the Treatment of Chronic Diabetic Foot Ulcers

PHASE3TerminatedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

July 27, 2021

Primary Completion Date

November 1, 2022

Study Completion Date

November 29, 2022

Conditions
Chronic Diabetic Foot Ulcers
Interventions
DRUG

ON101 Cream

Active ingredients: Extracts of Plectranthus amboinicus and Centella Asiatica

OTHER

Vehicle Cream

ON101 Cream Placebo

Trial Locations (14)

33016

Oneness Investigational Site, Miami Lakes

33165

Oneness Investigational Site, Miami

33321

Oneness Investigational Site, North Miami Beach

60056

Oneness Investigational Site, Mount Prospect

62269

Oneness Investigational Site, O'Fallon

62704

Oneness Investigational Site, Springfield

75251

Oneness Investigational Site, Dallas

78501

Oneness Investigational Site, McAllen

85206

Oneness Investigational Site, Mesa

91342

Oneness Investigational Site, Sylmar

92009

Oneness Investigational Site, Carlsbad

93710

Oneness Investigational Site, Fresno

94117

Oneness Investigational Site, San Francisco

94546

Oneness Investigational Site, Castro Valley

Sponsors
All Listed Sponsors
lead

Oneness Biotech Co., Ltd.

INDUSTRY